Frontlight ResearchEarly access
Trial site
Shanghai Cancer Hospital, Fudan University
- 1running trial
- 2closed trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Phase
- Phase 22 trials
- Phase 31 trial
- Status
- Completed2 trials
- Active, not recruiting1 trial
- Lead sponsor
- EMD Serono Research & Development Institute, Inc.3 trials
Running trials
Active, not recruiting
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026